Emmanuel Fortier
Overview
Explore the profile of Emmanuel Fortier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan S, Bernier A, Dapp D, Fortier E, Krajden M, King A, et al.
Can Liver J
. 2022 Aug;
1(2):94-105.
PMID: 35990718
Estimates are that more than 250,000 people in Canada are chronically infected with hepatitis C virus (HCV), and many more are unaware of their infection status. If untreated, chronic HCV...
2.
Fortier E, Hoj S, Sylvestre M, Artenie A, Minoyan N, Jutras-Aswad D, et al.
Int J Drug Policy
. 2021 Sep;
96:103439.
PMID: 34518099
Background: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may effect HCV infection...
3.
Artenie A, Fortier E, Sylvestre M, Hoj S, Minoyan N, Gauvin L, et al.
Int J Drug Policy
. 2021 Apr;
94:103205.
PMID: 33839598
Background: Little is known about how socioeconomic circumstances relate to injection frequencies among people who inject drugs (PWID) with diverse trajectories of injection. We aimed to characterize trajectories of injection...
4.
Fortier E, Sylvestre M, Artenie A, Minoyan N, Jutras-Aswad D, Roy E, et al.
Drug Alcohol Depend
. 2019 Dec;
206:107744.
PMID: 31785537
Background: The relationship between housing stability and drug injecting is complex, as both outcomes fluctuate over time. The objectives were to identify short-term trajectories of housing stability and injecting frequency...
5.
Cote P, Ghabrash M, Bruneau J, Roy E, Dubreucq S, Fortier E, et al.
Addict Behav
. 2019 May;
96:175-182.
PMID: 31108263
Background: High-risk injection behaviors are associated with high prevalence of mental health problems among people who inject drugs (PWID). However, whether the use of mental health services is associated with...
6.
Fortier E, Artenie A, Zang G, Jutras-Aswad D, Roy E, Grebely J, et al.
Addiction
. 2019 Apr;
114(8):1495-1503.
PMID: 30957310
Background And Aims: For most people who inject drugs (PWID), drug injecting follows a dynamic process characterized by transitions in and out of injecting. The objective of this investigation was...
7.
Puzhko S, Roy E, Jutras-Aswad D, Artenie A, Fortier E, Zang G, et al.
Int J Drug Policy
. 2017 Jul;
47:61-68.
PMID: 28666636
Background: Prescription opioid (PO) injection and poly-drug use have been associated with hepatitis C virus (HCV) infection among people who inject drugs (PWID). Poly-drug use is often a barrier to...
8.
Artenie A, Zang G, Daniel M, Fortier E, Jutras-Aswad D, Puzhko S, et al.
Int J Drug Policy
. 2017 Jun;
47:239-243.
PMID: 28587944
Background: It is unclear whether treatment and care for hepatitis C virus (HCV) infection can help people who inject drugs (PWID) modify their injection drug use behaviours. This study examined...
9.
Fortier E, Alavi M, Bruneau J, Micallef M, Perram J, Sockalingam S, et al.
J Addict Med
. 2016 Oct;
11(1):10-18.
PMID: 27775955
Objective: The aims of this study were to assess symptoms of depression, anxiety, and stress and associated sociodemographic factors among people living with chronic hepatitis C virus (HCV) infection with...
10.
Fortier E, Alavi M, Micallef M, Dunlop A, Balcomb A, Day C, et al.
Int J Drug Policy
. 2015 Jul;
26(11):1094-102.
PMID: 26145482
Background: The objective was to assess social functioning and its association with treatment intent, specialist assessment and treatment uptake for hepatitis C virus (HCV) infection among people with a history...